Did you already set up your mind about plasma therapy for COVID-19? | RAMPmedical News

In particular, there were 2 studies showing the opposite:

The 1st study shows a positive outcome for patients:

"Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience"


The 2nd study shows even a worsening:

"Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)"


As usual, we looked into the studies, and found that there is not only a different outcome, but also a mentionable difference in when the therapy had been applied. Emphasizing that the evidence is low regarding all treatments for COVID-19, in comparison to all available treatments, the early application of plasma therapy seems quite promising.

For details of our analysis regarding the efficacy and safety of the treatments for COVID-19, you can REGISTER under rampmedical.com. EU-awarded and free access.

RAMPmedical software


Henisaja GmbH


Kastanienallee 61

10119 Berlin


Chief Executive Officer:  Helene Schönewolf

+49 (0) 30 31 98 08 52​

Registered at the local court Berlin Charlottenburg HRB 167143 B

VAT: DE299921795

Follow us


Copyright 2020 | RAMPmedical